Epicardial Pacemaker Leads - Risk of Cardiac Strangulation in Pediatric...
Health Canada has been made aware of rare Canadian and international cases of cardiac strangulation in pediatric patients implanted with epicardial pacemaker leads. Health Canada is thus informing...
View ArticleEpicardial Pacemaker Leads - Risk of Cardiac Strangulation in Pediatric...
Health Canada is advising health care professionals and the public of a rare potential risk of cardiac strangulation for children implanted with epicardial leads connected to a pacemaker. These leads...
View ArticleExpanded Recall of Contaminated Foaming Hand Soap
Avmor Ltd. has expanded its recall of Antimicrobial Foaming Hand Soap (Triclosan 0.3%) to include 19 additional lots of this product. As a precautionary measure, Avmor Ltd. is also recalling 21 lots of...
View ArticleNew Safety Information: Interaction of Proton Pump Inhibitors (PPIs) with...
Health Canada is informing Canadians and Canadian health care practitioners that the labelling for methotrexate and Proton Pump Inhibitors is being updated to include information on a potential...
View ArticleNovartis Suspends Distribution of Seasonal Flu Vaccines Agriflu and Fluad in...
Agriflu and Fluad are two of the seasonal flu vaccines produced by Novartis that have been pulled from use in several European countries pending further examination of white floating material...
View ArticleVoluntary Suspension of Flu Vaccines (Agriflu and Fluad) Lifted
Health Canada has completed its review of safety information for Agriflu and Fluad and is releasing the two seasonal flu vaccines for immediate use. As a precautionary step, the products were...
View ArticleCarboplatin injection (600mg/60mL) - Visible Particles in One Lot
A recall has been initiated for one lot of Carboplatin injection distributed in Canada due to visible crystal like particulate matter observed during an inspection of retained samples. Vials of the...
View ArticleInfanrix Hexa - Voluntary Recall of Vaccine Due to Potential Microbiological...
Voluntary recall of GlaxoSmithKline (GSK) Infanrix Hexa Vaccine Lot A21CB242A due to potential microbiological contamination.
View ArticleRiata and Riata ST Silicone Endocardial Defibrillation Leads – Safety...
St. Jude Medical Inc., in collaboration with Health Canada, is providing this letter to re-iterate safety information and provide updated patient care resources and recommendations regarding insulation...
View ArticleExpanded Recall of X3 Clean Alcohol-Free Foaming Hand Sanitizer
Avmor Ltd. has expanded its recall of products to include four additional lots of the product X3 Clean Alcohol-Free Foaming Hand Sanitizer (Benzalkonium chloride 0.13%). The X3 product was originally...
View ArticleAGRIFLU and FLUAD - Health Canada Lifts the Suspension of Distribution of...
Novartis Pharmaceuticals Canada Inc., in collaboration with Health Canada, would like to inform you that the review of the safety information for AGRIFLU and FLUAD is now complete and Health Canada has...
View ArticleZocor (simvastatin) - New Safety Recommendations on Dosage Associated with...
The Canadian Product Monograph has been updated to reflect the increased risk of certain muscular problems (myopathy/rhabdomyolysis) when taking Zocor at a high dose or with certain foods/medications....
View ArticlePROLIA (denosumab) - Association with the Risk of Atypical Femoral Fractures
Cases of atypical femoral fractures associated with PROLIA (denosumab) treatment have been reported in patients participating in an ongoing clinical trial involving postmenopausal women with osteoporosis.
View ArticleThermography Machines not Authorized to Screen for Breast Cancer
Health Canada is advising Canadians and health care practitioners that no thermography (thermal imaging) machines have been approved to screen for breast cancer in Canada. Health Canada is not aware of...
View ArticleHealth Canada Suspends Licence of Chemical Testing Laboratory For Providing...
Health Canada has suspended the Establishment Licence of Chemi Pharmaceutical Inc. of Mississauga, Ont., after uncovering falsified testing results during the course of an inspection. Health Canada is...
View ArticlePradaxa/Pradax (dabigatran etexilate) - New Contraindication in Patients with...
Health Canada is advising health care professionals and the public that, based on new information, the blood-thinning drug Pradaxa is not to be used in patients with artificial heart valves (also known...
View ArticlePradaxa/Pradax (dabigatran etexilate) - New Contraindication in Patients with...
Health Canada is advising health care professionals and the public that, based on new information, the blood-thinning drug Pradaxa is not to be used in patients with artificial heart valves (also known...
View ArticlePradaxa (dabigatran, previously called Pradax): not to be used in patients...
Health Canada is advising health care professionals and the public that, based on new information, the blood-thinning drug Pradaxa is not to be used in patients with artificial heart valves (also known...
View ArticleNew Labelling Information for all Botulinum Toxin Products: Botox/Botox...
In order to help prevent medication errors with the use of botulinum toxin products currently available on the Canadian market, Health Canada will be requesting that all manufacturers of these products...
View ArticleNew statins labeling update: Risk of increased blood sugar levels and diabetes
Health Canada is informing Canadians of a labelling update for all cholesterol-lowering drugs (also known as statins) regarding the risk of increased blood sugar levels and a small increased risk of...
View Article
